EASL International Liver Congress (In Person)

Event description:

With 9000 delegates anticipated to attend and recognized as the "world’s greatest congress on the liver and hepatology", the EASL Congress 2023 present the perfect opportunity to connect on your hepatology program to discuss how you can leverage APAC, US or Europe for your global drug development plans in 2023 and beyond.

Novotech has robust relationships with investigators allowing to quickly identify the best sites for liver disease clinical studies. Over the last 25 years, Novotech has provided high-quality Liver disease CRO and drug development consulting services to numerous biotechnology companies using an approach adapted to the biotech model.